JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David M. Shahian
Warren A. Williamson
Lars G. Svensson
Richard S. D'Agostino
David T. Martin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahian, D. M.
Right arrow Articles by Venditti, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shahian, D. M.
Right arrow Articles by Venditti, F. J.

J Thorac Cardiovasc Surg 1995;109:1066-1074
© 1995 Mosby, Inc.


SURGERY FOR ACQUIRED HEART DISEASE

Transvenous versus transthoracic cardioverter-defibrillator implantation: A comparative analysis of morbidity, mortality, and survival

David M. Shahian, MD, Warren A. Williamson, MD, Lars G. Svensson, MD, Richard S. D'Agostino, MD, David T. Martin, MD, Jonathan R. Ellis, MD, Ferdinand J. Venditti, MD


Burlington, Mass.

From the Department of Thoracic and Cardiovascular Surgery and the Section of Cardiovascular Medicine, Lahey Clinic, Burlington, Mass.

Received for publication April 27, 1994. Accepted for publication Nov. 14, 1994. Address for reprints: David M. Shahian, MD, Department of Thoracic and Cardiovascular Surgery, Lahey Clinic, 41 Mall Rd., Burlington, MA 01805.

Abstract

The hypothesis that transvenous implantation of a cardioverter-defibrillator is associated with less morbidity than use of a transthoracic approach was investigated in a retrospective series of 146 patients. None of these patients had concomitant heart procedures, and the preoperative characteristics of the two groups were similar. When analyzed by actual technique used (transvenous, 57 patients; transthoracic, 89 patients) and by the intention-to-treat method (transvenous, 65 patients, 8 of whom actually underwent thoracotomy; thoracotomy, 81 patients), transvenous implantation was associated with a lower incidence of postoperative respiratory complications and atrial fibrillation. Total cardiac mortality and freedom from sudden cardiac death in the transvenous and transthoracic groups were comparable at 2 years. (J THORAC CARDIOVASC SURG 1995;109:1066-74)




This article has been cited by other articles:


Home page
Card Surg AdultHome page
H. M. Spotnitz
Surgical Implantation of Pacemakers and Automatic Defibrillators
Card. Surg. Adult, January 1, 2008; 3(2008): 1395 - 1428.
[Full Text]


Home page
CirculationHome page
M. J. Niebauer, B. Wilkoff, Y. Yamanouchi, T. Mazgalev, K. Mowrey, and P. Tchou
Iridium Oxide–Coated Defibrillation Electrode : Reduced Shock Polarization and Improved Defibrillation Efficacy
Circulation, November 18, 1997; 96(10): 3732 - 3736.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.